TickerKhojComparison · NSE · data 2026-11-02
Alkem Laboratories Ltd. vs Gland Pharma Ltd.
In plain words
Size: Alkem Laboratories Ltd. is about 1.2 times the market value of Gland Pharma Ltd..
Valuation (P/E): Gland Pharma Ltd. 45.2 vs Alkem Laboratories Ltd. 28.2.
Return on equity: Alkem Laboratories Ltd. 17.8% vs Gland Pharma Ltd. 10.5%.
Profit growth over 3 years: Alkem Laboratories Ltd. 32.7% a year vs Gland Pharma Ltd. 9.6% a year.
Debt to equity: Alkem Laboratories Ltd. 0.15 vs Gland Pharma Ltd. 0.03.
Differences in the numbers, not a recommendation of either stock.
Side by side
| ALKEM | GLAND | |
|---|---|---|
| Price | ₹5,088.5 | ₹3,096.1 |
| Market cap | ₹61,277 cr | ₹51,112 cr |
| P/E | 28.2 | 45.2 |
| P/B | — | — |
| ROE | 17.8% | 10.5% |
| ROCE | 17.8% | 12.0% |
| Debt / equity | 0.15 | 0.03 |
| Operating margin | 17.5% | 19.6% |
| Dividend yield | 1.03% | 0.65% |
| Sales growth, 3 years (yearly) | 8.2% | 21.1% |
| Profit growth, 3 years (yearly) | 32.7% | 9.6% |
| 1-year return | -7.9% | 61.3% |
| Revenue, last 12 months | ₹15,081 cr | ₹6,725 cr |
| Net profit, last 12 months | ₹2,158 cr | ₹1,129 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹520 cr | ₹317 cr |
| Quarter profit vs a year earlier | -21.7% | +47.1% |
| Promoter holding | 49.70% | 45.75% |
| Health check | Strong (6.8/10) | Strong (7.6/10) |
Common questions
Which has a higher P/E, Alkem Laboratories Ltd. or Gland Pharma Ltd.?
Gland Pharma Ltd. trades at the higher P/E (45.2 against 28.2). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Alkem Laboratories Ltd. (17.8% against 10.5%).
Which carries more debt?
Alkem Laboratories Ltd. has the higher debt-to-equity ratio (0.15 against 0.03).